CoChat
Sign Up
Cited by 239BRCA gene mutations in cancerRNA Research and SplicingGenomics and Rare Diseases

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants

Houdayer, Claude, Caux-Moncoutier, Virginie, Krieger, Sophie, Barrois, Michel, Bonnet, Françoise, Bourdon, Violaine, Bronner, Myriam, Buisson, Monique, Coulet, Florence, Gaildrat, Pascaline, Lefol, Cédrick, Léone, Mélanie, Mazoyer, Sylvie, Muller, Danielle, Remenieras, Audrey, Révillion, Françoise, Rouleau, Etienne, Sokolowska, Joanna, Vert, Jean-Philippe, Lidereau, Rosette, Soubrier, Florent, Sobol, Hagay, Sevenet, Nicolas, Bressac-de Paillerets, Brigitte, Hardouin, Agnès, Tosi, Mario, Sinilnikova, Olga M., Stoppa-Lyonnet, Dominique·2012·Human Mutation
DOI 10.1002/humu.22101
Open this paper in CoChat — free account

Abstract

Assessing the impact of variants of unknown significance (VUS) on splicing is a key issue in molecular diagnosis. This impact can be predicted by in silico tools, but proper evaluation and user guidelines are lacking. To fill this gap, we embarked upon the largest BRCA1 and BRCA2 splice study to date by testing 272 VUSs (327 analyses) within the BRCA splice network of Unicancer. All these VUSs were analyzed by using six tools (splice site prediction by neural network, splice site finder (SSF), MaxEntScan (MES), ESE finder, relative enhancer and silencer classification by unanimous enrichment, and human splicing finder) and the predictions obtained were compared with transcript analysis results. Combining MES and SSF gave 96% sensitivity and 83% specificity for VUSs occurring in the vicinity of consensus splice sites, that is, the surrounding 11 and 14 bases for the 5' and 3' sites, respectively. This study was also an opportunity to define guidelines for transcript analysis along with a tentative classification of splice variants. The guidelines drawn from this large series should be useful for the whole community, particularly in the context of growing sequencing capacities that require robust pipelines for variant interpretation.

Overview

Integrity signals

Registry

Crossref · 10.1002/humu.22101

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. Anczukow, 2008, Unclassified variants identified in BRCA1 exon 11: consequences on splicing, Genes Chromosomes Cancer, 47, 418, 10.1002/gcc.20546 · DOI
  2. Andreutti-Zaugg, 1997, Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques, Cancer Res, 57, 3288
  3. Ars, 2000, Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA, Nucleic Acids Res, 28, 1307, 10.1093/nar/28.6.1307 · DOI
  4. Bonnet, 2008, Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene, J Med Genet, 45, 438, 10.1136/jmg.2007.056895 · DOI
  5. Brezin, A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features, Mol Vis, 17, 1669
  6. Cartegni, 2003, ESEfinder: a web resource to identify exonic splicing enhancers, Nucleic Acids Res, 31, 3568, 10.1093/nar/gkg616 · DOI
  7. Caux-Moncoutier, 2011, EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: Application to BRCA1 and BRCA2 in 1,525 patients, Hum Mutat, 32, 325, 10.1002/humu.21414 · DOI
  8. Caux-Moncoutier, 2009, Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study, Eur J Hum Genet, 17, 1471, 10.1038/ejhg.2009.89 · DOI
  9. Corvelo, 2010, Genome-wide association between branch point properties and alternative splicing, PLoS Comput Biol, 6, e1001016, 10.1371/journal.pcbi.1001016 · DOI
  10. Dehainault, 2007, A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation, Eur J Hum Genet, 15, 473, 10.1038/sj.ejhg.5201787 · DOI
  11. Desmet, 2009, Human splicing finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Res, 37, e67, 10.1093/nar/gkp215 · DOI
  12. Doktor, 2011, SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3′ splice site, Hum Mutat, 32, 220, 10.1002/humu.21419 · DOI
  13. Fairbrother, 2002, Predictive identification of exonic splicing enhancers in human genes, Science, 297, 1007, 10.1126/science.1073774 · DOI
  14. Gaildrat, 2011, Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants, Methods Mol Biol, 653, 249, 10.1007/978-1-60761-759-4_15 · DOI · Paper page
  15. Hinzpeter, 2011, Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier, PLoS Genet, 6, e1001153, 10.1371/journal.pgen.1001153 · DOI
  16. Hofstra, 2008, Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance, Hum Mutat, 29, 1292, 10.1002/humu.20894 · DOI
  17. Holla, 2009, Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: comparison of wet-lab and bioinformatics analyses, Mol Genet Metab, 96, 245, 10.1016/j.ymgme.2008.12.014 · DOI
  18. Houdayer, 2008, Evaluation of in silico splice tools for decision-making in molecular diagnosis, Hum Mutat, 29, 975, 10.1002/humu.20765 · DOI
  19. Khan, Prolonged pursuit by optokinetic drum testing in asymptomatic female carriers of novel FRMD7 splice mutation c.1050 +5 G>A, Arch Ophthalmol, 129, 936, 10.1001/archophthalmol.2011.166 · DOI
  20. Lastella, 2006, In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects, BMC Genomics, 7, 243, 10.1186/1471-2164-7-243 · DOI
  21. Mahe, 2009, Virtual screening with support vector machines and structure kernels, Comb Chem High Throughput Screen, 12, 409, 10.2174/138620709788167926 · DOI
  22. Millevoi, 2010, The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding, Breast Cancer Res Treat, 120, 391, 10.1007/s10549-009-0392-3 · DOI
  23. Nalla, 2005, Automated splicing mutation analysis by information theory, Hum Mutat, 25, 334, 10.1002/humu.20151 · DOI
  24. Orban, 2003, Emerging roles of BRCA1 alternative splicing, Mol Pathol, 56, 191, 10.1136/mp.56.4.191 · DOI
  25. Plon, 2008, Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results, Hum Mutat, 29, 1282, 10.1002/humu.20880 · DOI · Paper page
  26. Reese, 1997, Improved splice site detection in Genie, J Comput Biol, 4, 311, 10.1089/cmb.1997.4.311 · DOI
  27. Shapiro, 1987, RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression, Nucleic Acids Res, 15, 7155, 10.1093/nar/15.17.7155 · DOI
  28. Spurdle, 2008, Prediction and assessment of splicing alterations: implications for clinical testing, Hum Mutat, 29, 1304, 10.1002/humu.20901 · DOI
  29. Svetnik, 2003, Random forest: a classification and regression tool for compound classification and QSAR modeling, J Chem Inf Comput Sci, 43, 1947, 10.1021/ci034160g · DOI
  30. Thery, 2011, Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes, Eur J Hum Genet, 19, 1052, 10.1038/ejhg.2011.100 · DOI
  31. Thomassen, 2012, Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members, Breast Cancer Res Treat, 132, 1009, 10.1007/s10549-011-1674-0 · DOI
  32. Tone, 2012, Enhanced exon 2 skipping caused by c.910G>A variant and alternative splicing of MEFV genes in two independent cases of familial Mediterranean fever., Mod Rheumatol, 22, 45, 10.1007/s10165-011-0461-4 · DOI
  33. Tournier, 2008, A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects, Hum Mutat, 29, 1412, 10.1002/humu.20796 · DOI
  34. Walker, 2011, Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity, Hum Mutat, 31, E1484, 10.1002/humu.21267 · DOI
  35. Whiley, 2011, Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary, Hum Mutat, 32, 678, 10.1002/humu.21495 · DOI
  36. Wimmer, 2000, Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients, Hum Genet, 106, 311, 10.1007/s004390051043 · DOI
  37. Wimmer, 2007, Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5′ splice-site disruption, Hum Mutat, 28, 599, 10.1002/humu.20493 · DOI
  38. Yeo, 2004, Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals, J Comput Biol, 11, 377, 10.1089/1066527041410418 · DOI
  39. Zhang, 2008, RNA landscape of evolution for optimal exon and intron discrimination, Proc Natl Acad Sci U S A, 105, 5797, 10.1073/pnas.0801692105 · DOI
  40. Zweig, 1993, Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin Chem, 39, 561, 10.1093/clinchem/39.4.561 · DOI

Cited by

Sorted by citations

See all 239

Metadata

Authors
Houdayer, C., Caux-Moncoutier, V., Krieger, S., Barrois, M., Bonnet, F., Bourdon, V., Bronner, M., Buisson, M., Coulet, F., Gaildrat, P., Lefol, C., Léone, M., Mazoyer, S., Muller, D., Remenieras, A., Révillion, F., Rouleau, E., Sokolowska, J., Vert, J.-P., Lidereau, R., Soubrier, F., Sobol, H., Sevenet, N., Bressac-de Paillerets, B., Hardouin, A., Tosi, M., Sinilnikova, O. M., & Stoppa-Lyonnet, D.
Affiliations
  • Sorbonne Paris Cité (FR)
  • Centre François Baclesse (FR)
  • Institut Gustave Roussy (FR)
  • Inserm (FR)
  • Institut Paoli-Calmettes (FR)
  • Centre Hospitalier Régional et Universitaire de Nancy (FR)
  • Lyon 1 Université (FR)
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Hôpital René Huguenin (FR)
  • Institut Strauss (FR)
Corresponding author
Houdayer, Claude
ORCID
Venue
Human Mutation
Publisher
Hindawi Limited
Published
2012-05-11
Volume
33
Issue
8
Pages
1228-1238
ISSN
1059-7794 (ISSN-L)
DOI
10.1002/humu.22101
OpenAlex
W1975196485
Cited by
239
References
0
Citations by year
2026: 3 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 25 · 2021: 27 · 2020: 22 · 2019: 23 · 2018: 27 · 2017: 23 · 2016: 14 · 2015: 22 · 2014: 11 · 2013: 17 · 2012: 3
FWCI
10.21
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1208 d)
Locations
  • Human Mutation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
BRCA1, BRCA2, variants of uncertain significance, splicing, splice site prediction, in silico tools, transcript analysis, variant interpretation, molecular diagnosis
MeSH terms
Exons, Female, Humans, RNA Splicing, BRCA1 Protein, BRCA2 Protein, Pathology, Molecular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review